Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Calabadion: A new agent to reverse the effects of benzylisoquinoline and steroidal neuromuscular-blocking agents.

Hoffmann U, Grosse-Sundrup M, Eikermann-Haerter K, Zaremba S, Ayata C, Zhang B, Ma D, Isaacs L, Eikermann M.

Anesthesiology. 2013 Aug;119(2):317-25. doi: 10.1097/ALN.0b013e3182910213.

PMID:
23549405
2.

Comparative Effectiveness of Calabadion and Sugammadex to Reverse Non-depolarizing Neuromuscular-blocking Agents.

Haerter F, Simons JC, Foerster U, Moreno Duarte I, Diaz-Gil D, Ganapati S, Eikermann-Haerter K, Ayata C, Zhang B, Blobner M, Isaacs L, Eikermann M.

Anesthesiology. 2015 Dec;123(6):1337-49. doi: 10.1097/ALN.0000000000000868.

3.

Optimum dose of neostigmine to reverse shallow neuromuscular blockade with rocuronium and cisatracurium.

Choi ES, Oh AY, Seo KS, Hwang JW, Ryu JH, Koo BW, Kim BG.

Anaesthesia. 2016 Apr;71(4):443-9. doi: 10.1111/anae.13398. Epub 2016 Feb 13.

4.
5.

Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.

Flockton EA, Mastronardi P, Hunter JM, Gomar C, Mirakhur RK, Aguilera L, Giunta FG, Meistelman C, Prins ME.

Br J Anaesth. 2008 May;100(5):622-30. doi: 10.1093/bja/aen037. Epub 2008 Apr 2.

PMID:
18385265
6.

[Influence of neostigmine on the course of neuromuscular blockade with rocuronium or cisatracurium: a randomized, double-blind trial].

Barrio J, San Miguel G, García V, Pelegrín F.

Rev Esp Anestesiol Reanim. 2007 Aug-Sep;54(7):399-404. Spanish.

PMID:
17953333
7.

Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.

Jones RK, Caldwell JE, Brull SJ, Soto RG.

Anesthesiology. 2008 Nov;109(5):816-24. doi: 10.1097/ALN.0b013e31818a3fee.

PMID:
18946293
8.

Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey.

de Boer HD, van Egmond J, van de Pol F, Bom A, Booij LH.

Br J Anaesth. 2006 Apr;96(4):473-9. Epub 2006 Feb 7.

PMID:
16464982
9.

A Novel Strategy to Reverse General Anesthesia by Scavenging with the Acyclic Cucurbit[n]uril-type Molecular Container Calabadion 2.

Diaz-Gil D, Haerter F, Falcinelli S, Ganapati S, Hettiarachchi GK, Simons JC, Zhang B, Grabitz SD, Moreno Duarte I, Cotten JF, Eikermann-Haerter K, Deng H, Chamberlin NL, Isaacs L, Briken V, Eikermann M.

Anesthesiology. 2016 Aug;125(2):333-45. doi: 10.1097/ALN.0000000000001199.

10.

The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.

Stevens JB, Walker SC, Fontenot JP.

Anesth Analg. 1997 Dec;85(6):1278-83.

PMID:
9390594
11.

A comparison of the neuromuscular blocking effects and reversibility of cisatracurium and atracurium.

Carroll MT, Mirakhur RK, Lowry D, Glover P, Kerr CJ.

Anaesthesia. 1998 Aug;53(8):744-8.

12.
13.

Neuromuscular blocking effects of cisatracurium and its antagonism with neostigmine in a canine model of autosomal-recessive centronuclear myopathy.

Martin-Flores M, Paré MD, Campoy L, Gleed RD.

Br J Anaesth. 2015 Dec;115(6):927-31. doi: 10.1093/bja/aev397.

PMID:
26582854
14.

A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion.

Mellinghoff H, Radbruch L, Diefenbach C, Buzello W.

Anesth Analg. 1996 Nov;83(5):1072-5.

PMID:
8895288
15.
16.

Postoperative residual curarization with cisatracurium and rocuronium infusions.

Cammu G, de Baerdemaeker L, den Blauwen N, de Mey JC, Struys M, Mortier E.

Eur J Anaesthesiol. 2002 Feb;19(2):129-34.

PMID:
11999596
17.

Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children.

Bevan JC, Collins L, Fowler C, Kahwaji R, Rosen HD, Smith MF, de Scheepers LD, Stephenson CA, Bevan DR.

Anesth Analg. 1999 Aug;89(2):333-9.

PMID:
10439743
18.

Reversing neuromuscular blockade: inhibitors of the acetylcholinesterase versus the encapsulating agents sugammadex and calabadion.

Haerter F, Eikermann M.

Expert Opin Pharmacother. 2016;17(6):819-33. doi: 10.1517/14656566.2016.1145667. Epub 2016 Mar 14. Review.

PMID:
26799963
19.

Supplemental Content

Support Center